How many common units will be outstanding after the rights offering?
As of September 20, 2019, the business day prior to the date of this registration statement, we had 39,565,454 common units issued and outstanding. We will issue a maximum of 33,487,904 common units in the rights offering through the exercise of subscription rights. Assuming the rights offering is fully subscribed, the gross proceeds thereof are used to redeem 33,487,904 preferred units, and we do not issue any additional common units after the record date, we anticipate that we will have approximately 73,053,358 common units outstanding and approximately 91,696,345 common units outstanding on a fully diluted basis, including 18,595,429 units issuable upon conversion of the preferred units that remain outstanding.
Our largest unitholder, Axar, owns, as of the record date, 7,748,435 common units and 39,764,491 preferred units, which are convertible, commencing 10 days following completion of this rights offering, into 18,595,429 common units. These holdings represent approximately 52% of the common units outstanding on a fully diluted basis. Assuming the rights offering is fully subscribed, and the gross proceeds are used to redeem 33,487,904 preferred units, Axar will own 7,748,435 common units and 18,595,429 preferred units, which are convertible, commencing 10 days following completion of this rights offering, representing approximately 29% of the common units outstanding on a fully diluted basis.
How much proceeds will the Partnership receive from the rights offering?
Assuming all the common units offered are sold, the gross proceeds from the rights offering will be up to approximately $40.2 million. See “—Use of Proceeds.” We intend to use all of the gross proceeds from this rights offering to redeem up to 33,487,904 of the preferred units from Axar and the other Purchasers. 18,595,429 of the preferred units purchased by Axar are not subject to redemption by us.
Are there risks in exercising my subscription rights?
Yes. The exercise of your subscription rights involves risks. Exercising your subscription rights involves the purchase of additional common units and should be considered as carefully as you would consider any other equity investment. Among other things, you should carefully consider the risks described under the headings “Risk Factors” in this prospectus and the documents incorporated by reference herein.
Are there risks in not exercising my rights?
Any rights that you do not exercise or sell will expire worthless and without payment to you on the expiration date. In addition, if you do not fully exercise your rights, you should expect that you will, at the completion of this rights offering, own a smaller proportional interest in us than you would have had if you fully had exercised your subscription rights, which could, in certain circumstances, result in a gain to you. See “—Risk Factors—Your interest in our company may be diluted as a result of this offering” and “In some circumstances, you may recognize income or gain as a result of the exercise of rights by other unitholders.”
May unitholders in all states participate in the rights offering?
Although we intend to distribute the rights to all unitholders, we reserve the right in some states to require unitholders, if they wish to participate, to state and agree upon exercise of their respective rights that they are acquiring the common units for investment purposes only, and that they have no present intention to resell or transfer any shares acquired. Our securities are not being offered in any jurisdiction where the offer is not permitted under applicable local laws.
18